Aflibercept-ayyh (aflibercept 2 mg biosimilar) for treatment-naïve retinal vascular diseases: early real-world experience - the APEX study.
Saved in:
| Title: | Aflibercept-ayyh (aflibercept 2 mg biosimilar) for treatment-naïve retinal vascular diseases: early real-world experience - the APEX study. |
|---|---|
| Authors: | Sharma A; Lotus Eye Hospital and Institute, Coimbatore, India., Shaer A; The Retina Service of Wills Eye Hospital, Mid Atlantic Retina, Philadelphia, PA, USA., Zhang J; The Retina Service of Wills Eye Hospital, Mid Atlantic Retina, Philadelphia, PA, USA., Regillo C; The Retina Service of Wills Eye Hospital, Mid Atlantic Retina, Philadelphia, PA, USA. |
| Corporate Authors: | Inter BIOS Group |
| Source: | Expert opinion on biological therapy [Expert Opin Biol Ther] 2026 Apr; Vol. 26 (4), pp. 415-422. Date of Electronic Publication: 2026 Apr 09. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101125414 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7682 (Electronic) Linking ISSN: 14712598 NLM ISO Abbreviation: Expert Opin Biol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1744-7682 |
|---|---|
| DOI: | 10.1080/14712598.2026.2655440 |
